Industry: Medical Devices & Consumables
Published Date: 2025-01-18
Pages: 83 Pages
Report ld: 3430927
Request Sample
Customized Report
Biologic and Medical Imaging Reagents Market Size(US$)

CAGR 2025-2031
9.2%
Market Size,2031
USD 46,350
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Biologic and Medical Imaging Reagents was valued at US$ 25250 million in the year 2024 and is projected to reach a revised size of US$ 46350 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.
The global well-known brands in Biologic and Medical Imaging Reagents include Cardinal Health(6.77%), Bracco(5.41%), Bayer HealthCare(3.48%), Curium Pharma(2.02%), Hengrui Medicine(2.67%), GE Healthcare(2.53%), Lantheus Medical Imaging(2.01%), Novartis (AAA)(2.77%), Thermo Fisher Scientific(2.16%), Jubilant DraxImage(1.63%), PerkinElmer(1.44%), Guerbet(1.75%), Nihon Medi-Physics(1.75%), YRPG(1.09%) and Others(62.52%).
The application area of Biologic and Medical Imaging Reagents include Hospitals, Clinics and Other.
In terms of types, Biologic and Medical Imaging Reagents can be divided into Nuclear Imaging (PET & SPECT) Reagents, Magnetic Resonance Imaging (MRI) Reagents, Fluorescence Imaging Reagents, Ultrasound and X-ray Contrast Reagents and Other.
On basis of geography, Biologic and Medical Imaging Reagents are manufactured in North America, Europe, China and Japan.
This report aims to provide a comprehensive presentation of the global market for Biologic and Medical Imaging Reagents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic and Medical Imaging Reagents.
The Biologic and Medical Imaging Reagents market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologic and Medical Imaging Reagents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologic and Medical Imaging Reagents companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologic and Medical Imaging Reagents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologic and Medical Imaging Reagents Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nuclear Imaging (PET & SPECT) Reagents
1.2.3 Magnetic Resonance Imaging (MRI) Reagents
1.2.4 Fluorescence Imaging Reagents
1.2.5 Ultrasound and X-ray Contrast Reagents
1.2.6 Other
1.3 Market by Application
1.3.1 Global Biologic and Medical Imaging Reagents Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologic and Medical Imaging Reagents Market Perspective (2020-2031)
2.2 Global Biologic and Medical Imaging Reagents Growth Trends by Region
2.2.1 Global Biologic and Medical Imaging Reagents Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biologic and Medical Imaging Reagents Historic Market Size by Region (2020-2025)
2.2.3 Biologic and Medical Imaging Reagents Forecasted Market Size by Region (2026-2031)
2.3 Biologic and Medical Imaging Reagents Market Dynamics
2.3.1 Biologic and Medical Imaging Reagents Industry Trends
2.3.2 Biologic and Medical Imaging Reagents Market Drivers
2.3.3 Biologic and Medical Imaging Reagents Market Challenges
2.3.4 Biologic and Medical Imaging Reagents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologic and Medical Imaging Reagents Players by Revenue
3.1.1 Global Top Biologic and Medical Imaging Reagents Players by Revenue (2020-2025)
3.1.2 Global Biologic and Medical Imaging Reagents Revenue Market Share by Players (2020-2025)
3.2 Global Biologic and Medical Imaging Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biologic and Medical Imaging Reagents Revenue
3.4 Global Biologic and Medical Imaging Reagents Market Concentration Ratio
3.4.1 Global Biologic and Medical Imaging Reagents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologic and Medical Imaging Reagents Revenue in 2024
3.5 Global Key Players of Biologic and Medical Imaging Reagents Head office and Area Served
3.6 Global Key Players of Biologic and Medical Imaging Reagents, Product and Application
3.7 Global Key Players of Biologic and Medical Imaging Reagents, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologic and Medical Imaging Reagents Breakdown Data by Type
4.1 Global Biologic and Medical Imaging Reagents Historic Market Size by Type (2020-2025)
4.2 Global Biologic and Medical Imaging Reagents Forecasted Market Size by Type (2026-2031)
5 Biologic and Medical Imaging Reagents Breakdown Data by Application
5.1 Global Biologic and Medical Imaging Reagents Historic Market Size by Application (2020-2025)
5.2 Global Biologic and Medical Imaging Reagents Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biologic and Medical Imaging Reagents Market Size (2020-2031)
6.2 North America Biologic and Medical Imaging Reagents Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biologic and Medical Imaging Reagents Market Size by Country (2020-2025)
6.4 North America Biologic and Medical Imaging Reagents Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologic and Medical Imaging Reagents Market Size (2020-2031)
7.2 Europe Biologic and Medical Imaging Reagents Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biologic and Medical Imaging Reagents Market Size by Country (2020-2025)
7.4 Europe Biologic and Medical Imaging Reagents Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologic and Medical Imaging Reagents Market Size (2020-2031)
8.2 Asia-Pacific Biologic and Medical Imaging Reagents Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biologic and Medical Imaging Reagents Market Size by Region (2020-2025)
8.4 Asia-Pacific Biologic and Medical Imaging Reagents Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologic and Medical Imaging Reagents Market Size (2020-2031)
9.2 Latin America Biologic and Medical Imaging Reagents Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biologic and Medical Imaging Reagents Market Size by Country (2020-2025)
9.4 Latin America Biologic and Medical Imaging Reagents Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologic and Medical Imaging Reagents Market Size (2020-2031)
10.2 Middle East & Africa Biologic and Medical Imaging Reagents Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biologic and Medical Imaging Reagents Market Size by Country (2020-2025)
10.4 Middle East & Africa Biologic and Medical Imaging Reagents Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Company Details
11.1.2 Cardinal Health Business Overview
11.1.3 Cardinal Health Biologic and Medical Imaging Reagents Introduction
11.1.4 Cardinal Health Revenue in Biologic and Medical Imaging Reagents Business (2020-2025)
11.1.5 Cardinal Health Recent Development
11.2 Bracco
11.2.1 Bracco Company Details
11.2.2 Bracco Business Overview
11.2.3 Bracco Biologic and Medical Imaging Reagents Introduction
11.2.4 Bracco Revenue in Biologic and Medical Imaging Reagents Business (2020-2025)
11.2.5 Bracco Recent Development
11.3 Bayer HealthCare
11.3.1 Bayer HealthCare Company Details
11.3.2 Bayer HealthCare Business Overview
11.3.3 Bayer HealthCare Biologic and Medical Imaging Reagents Introduction
11.3.4 Bayer HealthCare Revenue in Biologic and Medical Imaging Reagents Business (2020-2025)
11.3.5 Bayer HealthCare Recent Development
11.4 Curium Pharma
11.4.1 Curium Pharma Company Details
11.4.2 Curium Pharma Business Overview
11.4.3 Curium Pharma Biologic and Medical Imaging Reagents Introduction
11.4.4 Curium Pharma Revenue in Biologic and Medical Imaging Reagents Business (2020-2025)
11.4.5 Curium Pharma Recent Development
11.5 Hengrui Medicine
11.5.1 Hengrui Medicine Company Details
11.5.2 Hengrui Medicine Business Overview
11.5.3 Hengrui Medicine Biologic and Medical Imaging Reagents Introduction
11.5.4 Hengrui Medicine Revenue in Biologic and Medical Imaging Reagents Business (2020-2025)
11.5.5 Hengrui Medicine Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Biologic and Medical Imaging Reagents Introduction
11.6.4 GE Healthcare Revenue in Biologic and Medical Imaging Reagents Business (2020-2025)
11.6.5 GE Healthcare Recent Development
11.7 Lantheus Medical Imaging
11.7.1 Lantheus Medical Imaging Company Details
11.7.2 Lantheus Medical Imaging Business Overview
11.7.3 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Introduction
11.7.4 Lantheus Medical Imaging Revenue in Biologic and Medical Imaging Reagents Business (2020-2025)
11.7.5 Lantheus Medical Imaging Recent Development
11.8 Novartis (AAA)
11.8.1 Novartis (AAA) Company Details
11.8.2 Novartis (AAA) Business Overview
11.8.3 Novartis (AAA) Biologic and Medical Imaging Reagents Introduction
11.8.4 Novartis (AAA) Revenue in Biologic and Medical Imaging Reagents Business (2020-2025)
11.8.5 Novartis (AAA) Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Introduction
11.9.4 Thermo Fisher Scientific Revenue in Biologic and Medical Imaging Reagents Business (2020-2025)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 Jubilant DraxImage
11.10.1 Jubilant DraxImage Company Details
11.10.2 Jubilant DraxImage Business Overview
11.10.3 Jubilant DraxImage Biologic and Medical Imaging Reagents Introduction
11.10.4 Jubilant DraxImage Revenue in Biologic and Medical Imaging Reagents Business (2020-2025)
11.10.5 Jubilant DraxImage Recent Development
11.11 PerkinElmer
11.11.1 PerkinElmer Company Details
11.11.2 PerkinElmer Business Overview
11.11.3 PerkinElmer Biologic and Medical Imaging Reagents Introduction
11.11.4 PerkinElmer Revenue in Biologic and Medical Imaging Reagents Business (2020-2025)
11.11.5 PerkinElmer Recent Development
11.12 Guerbet
11.12.1 Guerbet Company Details
11.12.2 Guerbet Business Overview
11.12.3 Guerbet Biologic and Medical Imaging Reagents Introduction
11.12.4 Guerbet Revenue in Biologic and Medical Imaging Reagents Business (2020-2025)
11.12.5 Guerbet Recent Development
11.13 Nihon Medi-Physics
11.13.1 Nihon Medi-Physics Company Details
11.13.2 Nihon Medi-Physics Business Overview
11.13.3 Nihon Medi-Physics Biologic and Medical Imaging Reagents Introduction
11.13.4 Nihon Medi-Physics Revenue in Biologic and Medical Imaging Reagents Business (2020-2025)
11.13.5 Nihon Medi-Physics Recent Development
11.14 YRPG
11.14.1 YRPG Company Details
11.14.2 YRPG Business Overview
11.14.3 YRPG Biologic and Medical Imaging Reagents Introduction
11.14.4 YRPG Revenue in Biologic and Medical Imaging Reagents Business (2020-2025)
11.14.5 YRPG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Biologic and Medical Imaging Reagents market size was US$ 27340 million in 2025 and is forecast to reach a readjusted size of US$ 50190 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 96
USD 4250.00
(Single User License)
The global Biologic and Medical Imaging Reagents market was valued at US$ 27340 million in 2025 and is anticipated to reach US$ 50190 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 119
USD 2900.00
(Single User License)
The global market for Biologic and Medical Imaging Reagents was estimated to be worth US$ 27340 million in 2025 and is projected to reach US$ 50190 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 119
USD 3950.00
(Single User License)
The global Biologic and Medical Imaging Reagents market size was US$ 25250 million in 2024 and is forecast to a readjusted size of US$ 46350 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 97
USD 4250.00
(Single User License)
The global Biologic and Medical Imaging Reagents market is projected to grow from US$ 25250 million in 2024 to US$ 46350 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-08
Pages: 144
USD 4900.00
(Single User License)
In 2024, the global market size of Biologic and Medical Imaging Reagents was estimated to be worth US$ 25250 million and is forecast to reach approximately US$ 46350 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 142
USD 5900.00
(Single User License)
The global market for Biologic and Medical Imaging Reagents was estimated to be worth US$ 25250 million in 2024 and is forecast to a readjusted size of US$ 46350 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 102
USD 3950.00
(Single User License)
Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.
Published Date: 2024-01-18
Pages: 115
USD 3950.00
(Single User License)
The global Biologic and Medical Imaging Reagents market size was US$ 27340 million in 2025 and is forecast to reach a readjusted size of US$ 50190 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 96
The global Biologic and Medical Imaging Reagents market was valued at US$ 27340 million in 2025 and is anticipated to reach US$ 50190 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 119
The global market for Biologic and Medical Imaging Reagents was estimated to be worth US$ 27340 million in 2025 and is projected to reach US$ 50190 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 119
The global Biologic and Medical Imaging Reagents market size was US$ 25250 million in 2024 and is forecast to a readjusted size of US$ 46350 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 97
The global Biologic and Medical Imaging Reagents market is projected to grow from US$ 25250 million in 2024 to US$ 46350 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-08
Pages: 144
In 2024, the global market size of Biologic and Medical Imaging Reagents was estimated to be worth US$ 25250 million and is forecast to reach approximately US$ 46350 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 142
The global market for Biologic and Medical Imaging Reagents was estimated to be worth US$ 25250 million in 2024 and is forecast to a readjusted size of US$ 46350 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 102
Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.
Published: 2024-01-18
Pages: 115
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now